MedPath

University Hospital Tuebingen

🇩🇪Germany
Ownership
Private
Established
1388-01-01
Employees
-
Market Cap
-
Website
https://www.klinikum.uni-heidelberg.de/Startseite.2.0.html?&no_cache=1

Hypoglycemia Counterregulation and Symptom Perception With Insulin Detemir

Phase 4
Terminated
Conditions
Diabetes Mellitus
Hypoglycemia
First Posted Date
2007-06-25
Last Posted Date
2007-06-25
Lead Sponsor
University Hospital Tuebingen
Target Recruit Count
12
Registration Number
NCT00490893
Locations
🇩🇪

University of Tübingen, Medical Department, Tübingen, Germany

Randomized Trial Investigating Four Nasal CPAP Systems in the Management of Apnea of Prematurity

Not Applicable
Terminated
Conditions
Continuous Positive Airway Pressure
Apnea of Prematurity
CPAP
First Posted Date
2007-06-04
Last Posted Date
2007-08-24
Lead Sponsor
University Hospital Tuebingen
Target Recruit Count
16
Registration Number
NCT00482040

D3-GHR Polymorphism and Turner Syndrome

Completed
Conditions
Turner Syndrome
Short Stature
First Posted Date
2007-03-05
Last Posted Date
2015-12-03
Lead Sponsor
University Hospital Tuebingen
Registration Number
NCT00443144
Locations
🇩🇪

University-Children's Hospital, Tübingen, Germany

Steady State Serum and Epithelial Lining Fluid (ELF) Antibiotics Concentrations Under Continous Infusion

Terminated
Conditions
Pneumonia
Bacteremia
First Posted Date
2007-02-14
Last Posted Date
2008-06-09
Lead Sponsor
University Hospital Tuebingen
Target Recruit Count
40
Registration Number
NCT00435305
Locations
🇩🇪

Universitäsklinikum Tübingen, Klinik für Anästhesiologie und Intensivmedizin, Tübingen, Germany

Pemetrexed in Patients With Soft Tissue Sarcoma

Phase 2
Completed
Conditions
Sarcoma
First Posted Date
2007-01-29
Last Posted Date
2009-02-16
Lead Sponsor
University Hospital Tuebingen
Target Recruit Count
54
Registration Number
NCT00427466
Locations
🇩🇪

Medical Center II, University of Tuebingen, Tuebingen, Germany

Efficiency of a New Therapy to Treat Stenosis of Coronary Vessels in Comparison With Two Already Admitted Therapies

Phase 3
Conditions
Stable or Unstable Angina Pectoris
Myocardial Ischemia
First Posted Date
2006-11-08
Last Posted Date
2007-05-16
Lead Sponsor
University Hospital Tuebingen
Target Recruit Count
204
Registration Number
NCT00396929
Locations
🇩🇪

Abteilung Kardiologie und Kreislauferkrankungen, Medizinische Universitätsklinik und Poliklinik III, Universitätsklinikum Tübingen, Tuebingen, Germany

Everolimus in Combination With Cyclosporine A and Prednisolone for the Treatment of Graft Versus Host Disease

Phase 1
Terminated
Conditions
Graft Versus Host Disease
First Posted Date
2006-09-08
Last Posted Date
2014-05-29
Lead Sponsor
University Hospital Tuebingen
Target Recruit Count
10
Registration Number
NCT00373815
Locations
🇩🇪

Medical Center, Hematology & Oncology, University of Tuebingen, Tuebingen, Germany

Pharmacokinetic Interaction Study Between Budesonide and Metronidazole in Healthy Volunteers

Phase 4
Completed
Conditions
Healthy
First Posted Date
2006-06-20
Last Posted Date
2007-12-11
Lead Sponsor
University Hospital Tuebingen
Target Recruit Count
12
Registration Number
NCT00338910

Safety and Efficacy of Intratympanic Application of Dexamethasone Via Catheter in Patients With Sudden Hearing Loss

Phase 3
Completed
Conditions
Sudden Deafness
First Posted Date
2006-06-12
Last Posted Date
2008-02-05
Lead Sponsor
University Hospital Tuebingen
Target Recruit Count
23
Registration Number
NCT00335920
Locations
🇩🇪

Bundeswehrkrankenhaus Ulm, Ulm, Germany

🇩🇪

St. Vincentius Kliniken, Klinik für HNO Heilkunde, Karlsruhe, Germany

🇩🇪

Department of Otorhinolaryngology, University of Tubingen, Tubingen, Germany

Development of a New Method for Steady-State Measurement of NO Lung Diffusing Capacity in Healthy Subjects

Phase 1
Conditions
Pulmonary Diffusing Capacity
First Posted Date
2006-04-19
Last Posted Date
2007-06-14
Lead Sponsor
University Hospital Tuebingen
Target Recruit Count
107
Registration Number
NCT00315965
Locations
🇩🇪

University children´s hospital, Tuebingen, Germany

© Copyright 2025. All Rights Reserved by MedPath